6 hrs ago
The Total Economic Impact of Veracode's Cloud-Based Application Security Service
A Global 2000 financial services organization previously relied on a traditional on-premises security scanning tool, resulting in security assessments on a fraction of the applications in a portfolio of several thousand.
Mon Aug 18, 2014
Illumina Director Roy A. Whitfield Unloads 4,000 Shares
Illumina Director Roy A. Whitfield unloaded 4,000 shares of the company's stock on the open market in a transaction dated Friday, August 15th.
First insights into the transcriptome and development of new genomic...
Aleppo pine is a relevant conifer species for studying adaptive responses to drought and fire regimes in the Mediterranean region.
Sat Aug 16, 2014
Illumina SVP Christian O. Henry Unloads 20,000 Shares
Illumina SVP Christian O. Henry sold 20,000 shares of the stock on the open market in a transaction dated Wednesday, August 13th.
Fri Aug 15, 2014
Banker & Tradesman
NetBrain Leases 54,952 Square Feet In Burlington
NetBrain Technologies has leased 54,952 square feet at 15 Network Drive in Burlington from Nordblom Cos.
Thu Aug 14, 2014
Medical Device/Diagnostic Ind.
As Genomics Moves to Clinical Domain, Bio-IT Plays Key Role
Genomics is moving from research to clinical field, and bio-IT companies like Edico Genome may help power the transition to personalized medicine in a faster, accurate and cost-effective manner.
Tue Aug 12, 2014
Stifel Nicolaus Initiates Coverage on Illumina, Inc. at Buy, Announces $200.00 PT
In a report published Tuesday morning, Stifel analyst Miroslava Minkova initiated coverage on Illumina with a Buy rating and $200 price target.
Mon Aug 11, 2014
Illumina Now Covered by Analysts at Stifel Nicolaus
Several other analysts have also recently commented on the stock. Analysts at Goldman Sachs raised their price target on shares of Illumina from $184.00 to $187.00 in a research note on Tuesday, August 5th.
Nasdaq 100 Movers: ILMN, TSLA
In early trading on Monday, shares of Tesla Motors topped the list of the day's best performing components of the Nasdaq 100 index, trading up 5.2%.
Sun Aug 10, 2014
Illumina Receives Average Rating of "Buy" from Analysts
Illumina has been given a consensus recommendation of "Buy" by the twenty ratings firms that are presently covering the stock, AmericanBankingNews.com reports .
Thu Aug 07, 2014
Cancer Biomarker Market (Global & USA) to 2018 - Trends and Pipeline Analysis
Cancer Biomarker Market to 2018 is a comprehensive report on the cancer biomarker industry and its impact on the health system.
City Council addresses convention center expansion during special session
A discussion of the future of the San Diego Convention Center and consideration of a legal settlement with a victim of a wayward police officer top an unusually busy agenda for Thursday afternoon's City Council special meeting.
New Product Launch, New Board Member, Major Contracts, Successful...
Today, Analysts Review released its research reports regarding Abbott Laboratories , Illumina Inc. , General Dynamics Corp. , Raytheon Co.
Tue Aug 05, 2014
Veracode's Chris Wysopal joins Packetsled Board of Advisors
Wysopal, a globally recognized thought leader, will provide insight into evolving real-world attacks impacting enterprise business.
Mon Aug 04, 2014
Illumina Director Daniel Bradbury Sells 2,100 Shares
Illumina Director Daniel Bradbury sold 2,100 shares of Illumina stock on the open market in a transaction dated Monday, August 4th.
Fri Aug 01, 2014
Tigress Initiates Coverage On Illumina
In a report released Friday, Tigress analyst Philip Van Deusen initiated coverage on Illumina with a Buy rating.
Thu Jul 31, 2014
Customer Interaction Solutions
UK to Become World Number One in DNA Testing with Plan to...
The UK is set to become the world leader in ground-breaking genetic research into cancer and rare diseases, which will transform how diseases are diagnosed and treated, thanks to a package of investment worth more than A 300million, the Prime Minister will announce today.
Providence inks deal with 'world's richest doctor' for cancer and bio-informatics
Providence Health & Services is partnering with Dr. Patrick Soon-Shiong - described by Forbes as the "world's richest doctor" - to create the first clinical genomic network for cancer.
Illumina Appoints Jeff Huber to its Board of Directors
Mr. Huber is Senior Vice President at Google Inc. where he works at Google[x]. Mr. Huber joined Google in 2003 and led development for Google Maps , Google Apps , and Google Ads .
Tue Jul 29, 2014
Volatile Pacific Biosciences Continues To Make Progress
Oxford Nanotechnologies is getting more attention, but PacBio continues to do well with improving read lengths and accuracy and has plans for further improvements underway.